Department of Neurology, Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Neurobiol Aging. 2012 Aug;33(8):1850.e17-27. doi: 10.1016/j.neurobiolaging.2012.02.020. Epub 2012 Apr 13.
In order to assess the frequency of mutations in the known Alzheimer's disease causative genes in Turkish dementia patients we screened amyloid precursor protein (APP), PSEN1 and PSEN2 for mutations in a cohort of 98 Turkish dementia families. Six families were found to carry PSEN1 mutations (p.H163R, p.P264L, and p.H214Y) or variants suggested to cause the disease (p.L134R, p.L262V, and p.A396T). In 4 other families, previously reported PSEN2 variants were identified (p.R62H, p.R71W, p.M174V (n = 2), and p.S130L). The phenotype of the carriers varied from rapid progressing Alzheimer's disease to frontotemporal dementia, with spasticity and seizures also observed. Here we report a frequency of 11.2% of mutations and variants in the known Alzheimer disease genes in the dementia cohort studied and 24% in the early onset subgroup of patients, suggesting that mutations in these genes are not uncommon in Turkey and are associated with various phenotypes. We thus believe that genetic analysis should become a standardized diagnostic implement, not only for the identification of the genetic disease, but also for appropriate genetic counseling.
为了评估已知阿尔茨海默病致病基因在土耳其痴呆患者中的突变频率,我们在一个 98 个土耳其痴呆家庭的队列中筛选了淀粉样前体蛋白 (APP)、PSEN1 和 PSEN2 的突变。发现 6 个家庭携带 PSEN1 突变(p.H163R、p.P264L 和 p.H214Y)或提示致病的变异(p.L134R、p.L262V 和 p.A396T)。在另外 4 个家庭中,鉴定出了先前报道的 PSEN2 变异(p.R62H、p.R71W、p.M174V(n=2)和 p.S130L)。携带者的表型从快速进展性阿尔茨海默病到额颞叶痴呆不等,也观察到痉挛和癫痫。我们报告了在研究的痴呆队列中已知阿尔茨海默病基因的突变和变异频率为 11.2%,在早发患者亚组中为 24%,这表明这些基因的突变在土耳其并不罕见,并与各种表型相关。因此,我们认为遗传分析应该成为一种标准化的诊断手段,不仅用于确定遗传性疾病,也用于适当的遗传咨询。